These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10585138)

  • 1. Synthetic peptide vaccines effective in preventing virus infection.
    Ogasawara K
    Microbiol Immunol; 1999; 43(10):915-23. PubMed ID: 10585138
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiviral cytotoxic T lymphocyte induction and vaccination.
    Rouse BT; Norley S; Martin S
    Rev Infect Dis; 1988; 10(1):16-33. PubMed ID: 2451265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide vaccines for viral diseases.
    Francis MJ
    Sci Prog; 1990; 74(293 Pt 1):115-30. PubMed ID: 2267573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of protective immunity using minigenes.
    Whitton JL
    Ann N Y Acad Sci; 1994 Aug; 730():107-17. PubMed ID: 7521600
    [No Abstract]   [Full Text] [Related]  

  • 5. Peptide-induced antiviral protection by cytotoxic T cells.
    Schulz M; Zinkernagel RM; Hengartner H
    Proc Natl Acad Sci U S A; 1991 Feb; 88(3):991-3. PubMed ID: 1992491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective efficacy of intramuscular immunization with naked DNA.
    Donnelly JJ; Ulmer JB; Liu MA
    Ann N Y Acad Sci; 1995 Nov; 772():40-6. PubMed ID: 8546412
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of synthetic peptides in virology].
    Truyen U; Kaaden OR
    Dtsch Tierarztl Wochenschr; 1989 Feb; 96(2):69-72. PubMed ID: 2647457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How can peptide vaccines work?
    Rowlands DJ
    FEMS Microbiol Lett; 1992 Dec; 100(1-3):479-81. PubMed ID: 1282484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody and T cell responses to measles virus polypeptides and synthetic peptides.
    Mäkelä MJ; Ilonen J; Salmi AA
    FEMS Immunol Med Microbiol; 1993 Jan; 6(1):3-11. PubMed ID: 7682466
    [No Abstract]   [Full Text] [Related]  

  • 10. Protection induced by synthetic peptides corresponding to three serotypes in foot and mouth disease virus.
    Gale C; Doel T; Brooke G; White D; Mulcahy G; DiMarchi R
    Adv Exp Med Biol; 1989; 251():161-7. PubMed ID: 2558525
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhanced immunogenicity of a conformational epitope of human T-lymphotropic virus type 1 using a novel chimeric peptide.
    Frangione-Beebe M; Albrecht B; Dakappagari N; Rose RT; Brooks CL; Schwendeman SP; Lairmore MD; Kaumaya PT
    Vaccine; 2000 Dec; 19(9-10):1068-81. PubMed ID: 11137241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of Japanese encephalitis virus-specific cytotoxic T lymphocytes in humans by poxvirus-based JE vaccine candidates.
    Konishi E; Kurane I; Mason PW; Shope RE; Kanesa-Thasan N; Smucny JJ; Hoke CH; Ennis FA
    Vaccine; 1998 May; 16(8):842-9. PubMed ID: 9627942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of rhesus monkeys with synthetic peptide in a fusogenic proteoliposome elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes.
    Miller MD; Gould-Fogerite S; Shen L; Woods RM; Koenig S; Mannino RJ; Letvin NL
    J Exp Med; 1992 Dec; 176(6):1739-44. PubMed ID: 1460429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The changing face of virology: will the application of molecular techniques inevitably lead to new and better vaccines?
    Tannock GA
    Expert Rev Anti Infect Ther; 2004 Oct; 2(5):663-6. PubMed ID: 15482228
    [No Abstract]   [Full Text] [Related]  

  • 15. Initiation of cytotoxic T-cell response and protection of Balb/c mice by vaccination with an experimental ISCOMs respiratory syncytial virus subunit vaccine.
    Trudel M; Nadon F; Séguin C; Brault S; Lusignan Y; Lemieux S
    Vaccine; 1992; 10(2):107-12. PubMed ID: 1539463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination, immunopathology, and immunity.
    Hotchin J; Hotchin LB
    Science; 1991 Jul; 253(5016):210. PubMed ID: 1712986
    [No Abstract]   [Full Text] [Related]  

  • 17. Neutralizing antibody to Mengo virus, induced by synthetic peptides.
    Muir S; Weintraub JP; Hogle J; Bittle JL
    J Gen Virol; 1991 May; 72 ( Pt 5)():1087-92. PubMed ID: 1709682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards vaccines against human papillomavirus type-16 genital infections.
    Cason J; Khan SA; Best JM
    Vaccine; 1993; 11(6):603-11. PubMed ID: 8391738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Repertoire of epitopes of human immunodeficiency virus proteins and the search for vaccines and diagnostic kits].
    Kharchenko EP; Klimenko AP
    Dokl Akad Nauk SSSR; 1992; 322(1):189-92. PubMed ID: 1380907
    [No Abstract]   [Full Text] [Related]  

  • 20. Towards antiviral oligopeptide vaccines.
    Niesters HG; van der Zeijst BA
    Microbiol Sci; 1984 Jun; 1(3):55-8. PubMed ID: 6086077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.